Provided by Tiger Fintech (Singapore) Pte. Ltd.

CERo Therapeutics Holdings, Inc.

1.02
+0.05986.23%
Post-market: 0.9600-0.0600-5.88%19:55 EDT
Volume:256.87K
Turnover:251.73K
Market Cap:3.09M
PE:-0.04
High:1.03
Open:0.9500
Low:0.9420
Close:0.9602
Loading ...

Company Profile

Company Name:
CERo Therapeutics Holdings, Inc.
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
9
Office Location:
201 Haskins Way,Suite 230,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.

Directors

Name
Position
Brian G. Atwood
Director,Chairman
Chris Ehrlich
Chief Executive Officer and Director
Barbara Kosacz
Director
Caroline Loewy
Director
Kathleen LaPorte
Director

Shareholders

Name
Position
Chris Ehrlich
Chief Executive Officer and Director
Daniel Geffken
Chief Financial Officer
Douglas Fisher
President